FindTrial
Sign In

Correlation between serum bone morphogenetic protein 4 level and fatty lesions in the sacroiliac joints on MRI in patients with ankylosing spondylitis

Correlation between serum bone morphogenetic protein 4 level and fatty lesions in the sacroiliac joints on MRI in patients with ankylosing spondylitis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300078216
Enrollment
Unknown
Registered
2023-12-01
Start date
2023-12-01
Completion date
Unknown
Last updated
2023-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ankylosing spondylitis

Interventions

Experimental group (Ankylosing spondylitis with fatty lesions in the sacroiliac joints):no
Control group (Ankylosing spondylitis with no fatty lesions in the sacroiliac joints):None

Sponsors

The Fifth Affiliated Hospital,Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: Patients who meet the newly revised New York classification criteria in 1984 and have a clear diagnosis of ankylosing spondylitis.

Exclusion criteria

Exclusion criteria: (1) Patients with hepatitis B, active tuberculosis; (2) Patients with other types of spondyloarthritis; (3) Patients with osteoarthritis and other conditions that can cause new bone formation.

Design outcomes

Primary

MeasureTime frame
bone morphogenetic protein 4;—

Countries

China

Contacts

Public ContactZhong Shuping

The Fifth Affiliated Hospital,Sun Yat-sen University

zhshup@mail.sysu.edu.cn+86 139 2692 7926

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026